Financing led by funds managed by Blue Owl Capital; Senior Managing Director Kevin Raidy joins Latigo’s board Proceeds support advancement of company’s Nav1.8 inhibitor clinical programs and development of broader pipeline THOUSAND OAKS, Calif., March […]
Tag: Latigo Biotherapeutics
Latigo Biotherapeutics Appoints Tim Lugo as Chief Financial Officer and Adds Beth Seidenberg and Jim Tananbaum to Board of Directors
Former William Blair partner and group head, Lugo has facilitated raising more than $6 billion in capital through 40-plus transactions, including IPOs Veteran venture capitalists Drs. Seidenberg and Tananbaum will help scale and accelerate the […]